Cannabis use in Attention-Deficit/Hyperactivity Disorder (ADHD): A scoping review

被引:14
作者
Francisco, Ana Paula [1 ,2 ]
Lethbridge, Grace [3 ]
Patterson, Beth [3 ,4 ]
Bergmann, Carolina Goldman [4 ]
Van Ameringen, Michael [3 ,4 ,5 ]
机构
[1] Fed Univ Rio Grande UFRGS, Hosp Clin Porto Alegre, Lab Cronobiol & Sono, Rua Ramiro Barcelos,2350,Ave Protasio Alves,211-Sa, BR-90035903 Porto Alegre, Rio Grande do S, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Psiquiatria & Ciencias Comportame, BR-90010150 Porto Alegre, Rio Grande do S, Brazil
[3] McMaster Univ, MacAnxiety Res Ctr, L02-1057 Main St, Hamilton, ON L8S 1B7, Canada
[4] McMaster Univ, Dept Psychiat & Behav Neurosci, 1280 Main St, Hamilton, ON L8S 1B7, Canada
[5] McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, 1280 Main St, Hamilton, ON L8S 1B7, Canada
关键词
Cannabis; ADHD; Treatment; Cannabidiol; THC; Review; DEFICIT HYPERACTIVITY DISORDER; LA-TOURETTE SYNDROME; ADULT ADHD; CORTICAL THICKNESS; DOPAMINE RELEASE; CHILDHOOD ADHD; UNITED-STATES; MARIJUANA USE; SUBSTANCE USE; YOUNG-ADULTS;
D O I
10.1016/j.jpsychires.2022.11.029
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Treatments for Adult ADHD include stimulants, two non-stimulant medications, as well as cognitivebehavioral therapy (CBT). These pharmacological agents are often associated with side effects, contributing to poor treatment adherence. Patients with ADHD have regularly stated that cannabis has helped improve their ADHD symptoms; however, scientific literature describing the effects of cannabis on symptoms of ADHD is scarce.Methods: We systematically searched MEDLINE, EMBASE, EMCARE, PsycINFO, Web of Science, Cochrane Library, and Clinicaltrials.gov. The searches included all publications in English up to June 27, 2022. We included both experimental and observational studies that assessed the effect of cannabis on ADHD symptomatology and neuropsychiatric outcomes. To synthesize our current understanding of the potential effects of cannabis use on ADHD symptoms and pathophysiology, and the effects of ADHD on cannabis use, data was extracted from each study regarding the characteristics of its population, methods used to assess both cannabis consumption and ADHD symptoms, and key findings.Results: Our scoping review included a total of 39 studies. Only one study employed a randomized and placebocontrolled design to directly measure the effect of cannabis on ADHD, and no significant effect was observed for the study's primary outcome, the QbTest (Est = -0.17, 95% CI -0.40 to 0.07, p = 0.16). Most of the literature consists of cross-sectional studies that evaluate the association between ADHD severity and cannabis use. 15 studies addressed the neuropsychiatric effects of cannabis on ADHD by employing either a battery of neuropsychiatric tests or neuroimaging. The concentration and amount of THC and CBD used were not well measured in most of the studies. Although some studies indicated that cannabis improved ADHD symptoms, most studies indicated it worsened or had no effect on ADHD symptoms.Conclusions: Given the current evidence, cannabis is not recommended for people with ADHD. Limitations of the literature include the absence of objective measurements for cannabis exposure and ADHD symptoms, heterogenous definitions, oversampling, and small sample sizes.
引用
收藏
页码:239 / 256
页数:18
相关论文
共 103 条
[1]   Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis [J].
Ahlers, Joachim ;
Baumgartner, Christian ;
Augsburger, Mareike ;
Wenger, Andreas ;
Malischnig, Doris ;
Boumparis, Nikolaos ;
Berger, Thomas ;
Stark, Lars ;
Ebert, David D. ;
Haug, Severin ;
Schaub, Michael P. .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (04)
[2]  
Amen DG, 1998, J PSYCHOACTIVE DRUGS, V30, P209
[3]   Cannabis and Cannabinoids (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 58, pg 97, 2016) [J].
Abramowicz, Mark ;
Zuccotti, Gianna ;
Pflomm, Jean-Marie .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (22) :2424-2425
[4]  
[Anonymous], 2015, World Drug Report 2015
[5]  
Barkley R.A., 2010, J ADHD RELATED DISOR, V1, P5
[6]   CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial [J].
Baumgartner, Christian ;
Schaub, Michael Patrick ;
Wenger, Andreas ;
Malischnig, Doris ;
Augsburger, Mareike ;
Walter, Marc ;
Berger, Thomas ;
Stark, Lars ;
Ebert, David Daniel ;
Keough, Matthew T. ;
Haug, Severin .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (04)
[7]   Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor [J].
Beltramo, M ;
de Fonseca, FR ;
Navarro, M ;
Calignano, A ;
Gorriti, MA ;
Grammatikopoulos, G ;
Sadile, AG ;
Giuffrida, A ;
Piomelli, D .
JOURNAL OF NEUROSCIENCE, 2000, 20 (09) :3401-3407
[8]   Attention-deficit hyperactivity disorder [J].
Biederman, J ;
Faraone, SV .
LANCET, 2005, 366 (9481) :237-248
[9]   Further human evidence for striatal dopamine release induced by administration of a†9-tetrahydrocannabinol (THC): selectivity to limbic striatum [J].
Bossong, Matthijs G. ;
Mehta, Mitul A. ;
van Berckel, Bart N. M. ;
Howes, Oliver D. ;
Kahn, Rene S. ;
Stokes, Paul R. A. .
PSYCHOPHARMACOLOGY, 2015, 232 (15) :2723-2729
[10]   ADHD burden of illness in older adults: a life course perspective [J].
Brod, Meryl ;
Schmitt, Eva ;
Goodwin, Marc ;
Hodgkins, Paul ;
Niebler, Gwendolyn .
QUALITY OF LIFE RESEARCH, 2012, 21 (05) :795-799